RSPH holdings
Invesco S&P 500 Equal Weight Health Care ETF
Positions
63 stored of 63 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Bio-Techne Corp. | US09073M1045 | 09073M104 | 2.126% | $16.3M | Equity (common) | Corporate | United States | USD |
| 2 | IQVIA Holdings Inc. | US46266C1053 | 46266C105 | 1.999% | $15.3M | Equity (common) | Corporate | United States | USD |
| 3 | Baxter International Inc. | US0718131099 | 071813109 | 1.994% | $15.3M | Equity (common) | Corporate | United States | USD |
| 4 | Regeneron Pharmaceuticals, Inc. | US75886F1075 | 75886F107 | 1.963% | $15.1M | Equity (common) | Corporate | United States | USD |
| 5 | Mettler-Toledo International Inc. | US5926881054 | 592688105 | 1.943% | $14.9M | Equity (common) | Corporate | United States | USD |
| 6 | Charles River Laboratories International, Inc. | US1598641074 | 159864107 | 1.933% | $14.8M | Equity (common) | Corporate | United States | USD |
| 7 | Veeva Systems Inc. Veeva Systems Inc., Class A | US9224751084 | 922475108 | 1.927% | $14.8M | Equity (common) | Corporate | United States | USD |
| 8 | DaVita Inc. | US23918K1088 | 23918K108 | 1.871% | $14.4M | Equity (common) | Corporate | United States | USD |
| 9 | Moderna, Inc. | US60770K1079 | 60770K107 | 1.845% | $14.1M | Equity (common) | Corporate | United States | USD |
| 10 | Thermo Fisher Scientific Inc. | US8835561023 | 883556102 | 1.842% | $14.1M | Equity (common) | Corporate | United States | USD |
| 11 | Abbott Laboratories | US0028241000 | 002824100 | 1.834% | $14.1M | Equity (common) | Corporate | United States | USD |
| 12 | Bristol-Myers Squibb Co. | US1101221083 | 110122108 | 1.819% | $13.9M | Equity (common) | Corporate | United States | USD |
| 13 | Universal Health Services, Inc. Universal Health Services, Inc., Class B | US9139031002 | 913903100 | 1.800% | $13.8M | Equity (common) | Corporate | United States | USD |
| 14 | Labcorp Holdings Inc. | US5049221055 | 504922105 | 1.781% | $13.7M | Equity (common) | Corporate | United States | USD |
| 15 | Quest Diagnostics Inc. | US74834L1008 | 74834L100 | 1.768% | $13.6M | Equity (common) | Corporate | United States | USD |
| 16 | Amgen Inc. | US0311621009 | 031162100 | 1.766% | $13.5M | Equity (common) | Corporate | United States | USD |
| 17 | Incyte Corp. | US45337C1027 | 45337C102 | 1.755% | $13.5M | Equity (common) | Corporate | United States | USD |
| 18 | Becton, Dickinson and Co. | US0758871091 | 075887109 | 1.733% | $13.3M | Equity (common) | Corporate | United States | USD |
| 19 | DexCom, Inc. | US2521311074 | 252131107 | 1.728% | $13.2M | Equity (common) | Corporate | United States | USD |
| 20 | AbbVie Inc. | US00287Y1091 | 00287Y109 | 1.727% | $13.2M | Equity (common) | Corporate | United States | USD |
| 21 | Viatris Inc. | US92556V1061 | 92556V106 | 1.724% | $13.2M | Equity (common) | Corporate | United States | USD |
| 22 | Revvity, Inc. | US7140461093 | 714046109 | 1.719% | $13.2M | Equity (common) | Corporate | United States | USD |
| 23 | Cencora, Inc. | US03073E1055 | 03073E105 | 1.713% | $13.1M | Equity (common) | Corporate | United States | USD |
| 24 | Steris PLC | IE00BFY8C754 | G8473T100 | 1.700% | $13.0M | Equity (common) | Corporate | Ireland | USD |
| 25 | Insulet Corp. | US45784P1012 | 45784P101 | 1.699% | $13.0M | Equity (common) | Corporate | United States | USD |
| 26 | Merck & Co., Inc. | US58933Y1055 | 58933Y105 | 1.692% | $13.0M | Equity (common) | Corporate | United States | USD |
| 27 | Vertex Pharmaceuticals Inc. | US92532F1003 | 92532F100 | 1.691% | $13.0M | Equity (common) | Corporate | United States | USD |
| 28 | ResMed Inc. | US7611521078 | 761152107 | 1.688% | $12.9M | Equity (common) | Corporate | United States | USD |
| 29 | Henry Schein, Inc. | US8064071025 | 806407102 | 1.683% | $12.9M | Equity (common) | Corporate | United States | USD |
| 30 | McKesson Corp. | US58155Q1031 | 58155Q103 | 1.680% | $12.9M | Equity (common) | Corporate | United States | USD |
| 31 | Johnson & Johnson | US4781601046 | 478160104 | 1.666% | $12.8M | Equity (common) | Corporate | United States | USD |
| 32 | HCA Healthcare, Inc. | US40412C1018 | 40412C101 | 1.666% | $12.8M | Equity (common) | Corporate | United States | USD |
| 33 | Invesco Private Prime Fund | Not reported | Not reported | 1.663% | $12.8M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 34 | Gilead Sciences, Inc. | US3755581036 | 375558103 | 1.658% | $12.7M | Equity (common) | Corporate | United States | USD |
| 35 | Cooper Cos., Inc. (The) | US2166485019 | 216648501 | 1.655% | $12.7M | Equity (common) | Corporate | United States | USD |
| 36 | GE HealthCare Technologies Inc. | US36266G1076 | 36266G107 | 1.651% | $12.7M | Equity (common) | Corporate | United States | USD |
| 37 | CVS Health Corp. | US1266501006 | 126650100 | 1.649% | $12.6M | Equity (common) | Corporate | United States | USD |
| 38 | Zimmer Biomet Holdings, Inc. | US98956P1021 | 98956P102 | 1.649% | $12.6M | Equity (common) | Corporate | United States | USD |
| 39 | Medtronic PLC | IE00BTN1Y115 | G5960L103 | 1.647% | $12.6M | Equity (common) | Corporate | Ireland | USD |
| 40 | Cardinal Health, Inc. | US14149Y1082 | 14149Y108 | 1.647% | $12.6M | Equity (common) | Corporate | United States | USD |
| 41 | Danaher Corp. | US2358511028 | 235851102 | 1.642% | $12.6M | Equity (common) | Corporate | United States | USD |
| 42 | Solventum Corp. | US83444M1018 | 83444M101 | 1.635% | $12.5M | Equity (common) | Corporate | United States | USD |
| 43 | Stryker Corp. | US8636671013 | 863667101 | 1.629% | $12.5M | Equity (common) | Corporate | United States | USD |
| 44 | Agilent Technologies, Inc. | US00846U1016 | 00846U101 | 1.628% | $12.5M | Equity (common) | Corporate | United States | USD |
| 45 | Biogen Inc. | US09062X1037 | 09062X103 | 1.619% | $12.4M | Equity (common) | Corporate | United States | USD |
| 46 | Waters Corp. | US9418481035 | 941848103 | 1.610% | $12.3M | Equity (common) | Corporate | United States | USD |
| 47 | West Pharmaceutical Services, Inc. | US9553061055 | 955306105 | 1.593% | $12.2M | Equity (common) | Corporate | United States | USD |
| 48 | UnitedHealth Group Inc. | US91324P1021 | 91324P102 | 1.572% | $12.1M | Equity (common) | Corporate | United States | USD |
| 49 | Eli Lilly and Co. | US5324571083 | 532457108 | 1.572% | $12.1M | Equity (common) | Corporate | United States | USD |
| 50 | IDEXX Laboratories, Inc. | US45168D1046 | 45168D104 | 1.558% | $11.9M | Equity (common) | Corporate | United States | USD |
| 51 | Edwards Lifesciences Corp. | US28176E1082 | 28176E108 | 1.550% | $11.9M | Equity (common) | Corporate | United States | USD |
| 52 | Humana Inc. | US4448591028 | 444859102 | 1.547% | $11.9M | Equity (common) | Corporate | United States | USD |
| 53 | Align Technology, Inc. | US0162551016 | 016255101 | 1.537% | $11.8M | Equity (common) | Corporate | United States | USD |
| 54 | Pfizer Inc. | US7170811035 | 717081103 | 1.512% | $11.6M | Equity (common) | Corporate | United States | USD |
| 55 | Boston Scientific Corp. | US1011371077 | 101137107 | 1.496% | $11.5M | Equity (common) | Corporate | United States | USD |
| 56 | Centene Corp. | US15135B1017 | 15135B101 | 1.474% | $11.3M | Equity (common) | Corporate | United States | USD |
| 57 | Zoetis Inc. | US98978V1035 | 98978V103 | 1.471% | $11.3M | Equity (common) | Corporate | United States | USD |
| 58 | Cigna Group (The) | US1255231003 | 125523100 | 1.459% | $11.2M | Equity (common) | Corporate | United States | USD |
| 59 | Elevance Health, Inc. | US0367521038 | 036752103 | 1.436% | $11.0M | Equity (common) | Corporate | United States | USD |
| 60 | Intuitive Surgical, Inc. | US46120E6023 | 46120E602 | 1.327% | $10.2M | Equity (common) | Corporate | United States | USD |
| 61 | Invesco Private Government Fund | Not reported | Not reported | 0.594% | $4.6M | Short-term investment vehicles (cash funds) | Private fund | United States | USD |
| 62 | Invesco Government & Agency Portfolio Invesco Government & Agency Portfolio, Institutional Class | US8252528851 | 825252885 | 0.045% | $347K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 63 | TPG Inc. | US436CVR0216 | 436CVR021 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |